Bibliometric and visual analysis: A comprehensive tracking of global research trends on ablation and tumor immune microenvironment from 2016 to 2025 Authors: Sibo Meng, Jiaxin Li, Fangli Cao, Hongxin Niu Published: 2026 ABSTRACT Highlight•Ablation is now an increasingly widely used local treatment approach in the field of tumor therapy.•It is widely acknowledged that ablation affects the tumor immune microenvironment.•Ablation may enhance the efficacy of immunotherapy.•The connection between ablation and the immune microenvironment is a hot research area currently.Keywords: Ablation, Tumor immune microenvironment, Immunotherapy, Bibliometrics, Web of science Introduction Since the advent of the Seldinger technique in the 1950s, interventional radiology has rapidly evolved from a technical subspecialty to an independent medical discipline. As a branch of this field, interventional oncology comprehensively applies interventional techniques to the diagnosis, treatment and management of cancer. With the increasing acceptance of percutaneous ablation therapy by patients, the number of people choosing interventional oncology treatment has grown exponentially [1]. Especially in the treatment of liver malignant tumors, interventional medicine has gradually replaced the traditional radiotherapy and chemotherapy treatment model and has become an important component of the MDT team [2]. Interventional treatment methods include cryoablation, radiofrequency ablation (RFA), microwave ablation (MWA), irreversible electroporation (IRE), high-intensity focused ultrasound (HIFU), transcatheter arterial chemoembolization (TACE), and transcatheter arterial radioembolization (TARE). The development of image-guided technology and the creation of new interventional devices have led interventional treatment to become more precise and minimally invasive. At the same time, the maturity of artificial intelligence (AI) assisted decision-making systems and the application of robot-assisted interventional technology have driven interventional treatment towards intelligence [3]. Traditionally, interventional techniques were mainly used for the diagnosis and treatment of cardiovascular diseases, and later expanded to the fields of oncology and neurointervention. Nowadays, interventional techniques are increasingly utilized by more disciplines, and their indications are also continuously broadening. For instance, in orthopedics, interventional techniques are applied to the treatment of bone metastases, and in gynecology, they are used for the treatment of uterine fibroids [4]. The combined application of interventional therapy and immunotherapy has achieved unexpected results. Interventional therapy can effectively promote local tumor control and facilitate the release of new tumor antigens, while immunotherapy enhances the anti-tumor immune response by recognizing these new antigens. The combination of the two can produce a synergistic effect and improve treatment outcomes. For example, EMERALD-1 is an international Phase III study that evaluated the efficacy of durvalumab + bevacizumab + TACE versus TACE + placebo in intermediate-stage hepatocellular carcinoma. The results showed that the median progression-free survival of the combination therapy group was 15.0 months, compared with 8.2 months in the control group, providing a new treatment option for patients [5]. Another study involving patients with hepatocellular carcinoma (HCC) at Barcelona Clinic Liver Cancer (BCLC) stage C, including those with portal vein tumor thrombus (PVTT), adopted a combination therapy approach that integrated transcatheter arterial chemoembolization (TACE), hepatic artery infusion chemotherapy (HAIC), donafenib, and immune checkpoint inhibitors. This quadruple therapy significantly prolonged the survival of patients, with safety profiles similar to those of targeted and immunotherapy, offering a new clinical perspective and promising treatment option for advanced HCC [6]. The BOOSTER phase II trial evaluated the efficacy of ablation combined with immune checkpoint inhibitors in patients with advanced non-small cell lung cancer who had residual oligometastases after first-line immunotherapy. The median progression-free survival was 26.7 months in the combination treatment group and 11.7 months in the maintenance treatment group. Ablation can induce tumor necrosis, release antigens to activate T cells and trigger an anti-tumor response, and also promote CD4+/CD8+ T cell infiltration and reduce immunosuppressive cells, thereby enhancing the effect of immunotherapy [7]. This study describes the use of cryoablation combined with anti-PD-1 antibodies and lenvatinib (CASTLE regimen) showing an ORR of 75%, a median PFS of 16.8 months and a median OS of 25.4 months in patients diagnosed with advanced cholangiocarcinoma. Others have even been cured. The abscopal effect of cryoablation induces a systemic anti-tumor immune response. It has shown substantial improvement in therapeutic efficiency in conjunction with immonotherpy and targeted therapy [8]. The tumor immune microenvironment is a critical determining factor of tumorigenesis, progress and therapeutical efficacy. The tumor-specific expression of IGSF9 is positively associated with the level of senescence of TAMs. IGSF9 induces TAM senescence and represses T cell activation, enabling tumor escape from immune attack. IVU treatment plays a protective role in reversing TAM senescence and immunosuppression, activating T cells, and inhibiting tumor growth [9]. The Bladder Cancer Immune Prognostic Index (BCIPI) was extracted, integrating and modeling 33 immune-related gene features to predict overall survival as well as response to anti-PD-L1 therapy based on factors such as metabolism and extracellular matrix. Patients who benefit from immunotherapy are characterized by higher infiltration of immune cells, as indicated by high BCIPI scores [10]. The image of the spatial distribution of immune microenvironment in hepatocellular carcinoma(HCC) has been mapped by spatial transcriptomics technology, which visually shows that there is a correlation between the infiltration pattern of immune cells and tumor heterogeneity as well as patient prognosis [11]. Currently, there is no bibliometric analysis literature on ablation and the tumor immune microenvironment. Bibliometrics is characterized by quantitative analysis of literature data to discover the evolutions in research trends, citation effect and therelationship among researches. To give a visual overview of the current status of this field, to organize the trends and key nodes in its development process over the past 10 years, and an additional reference for subsequent research in this field. Materials and methods Data sources and collection On February 21, 2026, relevant literature in the field of ablation and the tumor immune microenvironment is directly retrieved from the Web of Science Core Collection (WoSCC) database, spanning January 1, 2016, to December 31, 2025. Methodology: The data source is the Science Citation Index Expanded (SCI-Expanded). Two researchers (J.L. and S.M.) independently search for relevant literature in the WoSCC database and save the results in the format of "full record with cited references." The search formula and data screening process are illustrated in Supplementary Figure 1. The screening criteria are as follows: (1) Articles published in the current year are excluded; (2) Only "Articles" and "Review Articles" are included as document types; (3) The language is restricted to English. Ultimately, 5328 papers are selected for analysis. It is worth noting that, in the last paragraph of the "Results" section, when obtaining the intersection of articles with "immunotherapy," the same search method is applied, yielding 537 included articles. Bibliometric analysis and visualization After the screening process is completed, the literature in TXT format containing "full records and citations" is downloaded and then imported into CiteSpace 6.4.R1 [12] and VOSviewer 1.6.18 software. The analysis is conducted using the WoSCC online analysis platform. The WoSCC online analysis platform is employed to extract information such as the annual number of publications, the top ten countries/regions, institutions, authors, journals, and highly cited literature in terms of publication volume. CiteSpace 6.4.R1, a commonly used bibliometric tool developed by Professor Chaomei Chen, is utilized for burst detection, cluster visualization, timeline analysis, and more. VOSviewer 1.6.18 software is used to analyze co-authorship relationships among institutions, countries/regions, and authors, and to generate relevant visualizations. The Bibliometrix (version 5.0) [13] R package is employed to analyze word clouds, trending topics, and graphical displays of the annual number of published articles. Reusult An overview of publication trends This analysis reveals that the number of papers on the topics of ablation and the tumor immune microenvironment has significantly increased over the past decade (Fig. 1A). In 2016, only 86 related articles were published, but by 2025, the annual publication volume had risen to 1041. Although the total number of papers in some individual years slightly decreased compared to the previous year, it remained at a high level, indicating that it has been a hot research area. Geographically, China leads in the number of published papers, followed by the United States, South Korea, India, Singapore, Germany, the United Kingdom, Italy, Japan, and Australia (Fig. 1B and Supplementary Table 1). The publication trends of the top five countries over the past ten years are shown in Fig. 1C. Additionally, the global collaboration network (Fig. 1D) indicates that there is close cooperation among countries, with China and the United States having the closest collaboration. This reflects the need for an international perspective in this field of research. In summary, it demonstrates that there is widespread research enthusiasm for this field globally. Overview of Publication Trends. A: Annual Publication Volume Over the Past Decade; B: Publication Volume by Country; C: Publication Trends of the Top 5 Countries in Terms of Publication Volume; D: International Collaboration in Publication Volume. Journals with the most published articles in the field and burst analysis Supplementary Figure 2A shows the journals that have published the most articles in this field, among which ACS Applied Materials & Interfaces and Chemical Engineering Journal have published the largest number of articles (see Supplementary Table 2). Supplementary Figure 2B ranks the influence of the journals in this field by H-index, showing the influence of ACS Nano and Biomaterials in this field's research. Supplementary Figure 2C visualizes the temporal continuity of research topics through a timeline, demonstrating the development, connections, and collaboration dynamics in the related field. Supplementary Figure 2D lists the start and end times of the BURST of references, including the year of hot spot emergence and duration, etc., presenting the hot years of articles in chronological order, reflecting the influence and temporal evolution of the journals in this field. Authors with outstanding contributions in this field An analysis of the contributions and collaboration of researchers in this field is presented. Supplementary Figure 3A shows the authors who have published the most research results in this field, among whom ZHANG Y, LIU Y, and WANG Y have published the most papers. Supplementary Figure 3B shows the annual publication numbers of the top ten authors in terms of publication quantity over the past ten years. Supplementary Table 3 comprehensively presents the authors with the highest number of papers and the highest H-INDEX, reflecting their influence and contribution in the research of this field. Supplementary Figure 3C visually presents the collaboration among authors, indicating that in-depth and extensive collaboration is needed in this field's research. Supplementary Figure 3D shows the connections among authors and the correlations of research directions through a timeline. Supplementary Figure 3E presents the influence of authors in different time periods through BURST. It comprehensively reveals the academic influence and collaboration of outstanding researchers in this field. Key research institutions in this field An analysis was conducted on the research institutions with outstanding contributions in this field and their cooperative relationships. Supplementary Figure 4A lists the top ten research institutions in terms of the number of published papers, with the top three being Chinese Academy of Sciences, Sun Yat-sen University, and Shanghai Jiao Tong University. Supplementary Table 4 shows the number of published papers and H-INDEX of these institutions over the past ten years. Supplementary Figure 4B presents the cooperative relationships among the institutions, where the size and color of the nodes represent the number of published papers and the closeness of research topics, respectively. Supplementary Figure 4C visualizes the correlation of research directions of the institutions in the form of a timeline. Supplementary Figure 4D details the time span of the BURST period of the more influential institutions. In conclusion, the analysis reveals the influence of the major research institutions in this field, the cooperative situation among them, and their correlations. Key research countries in this field Continue to demonstrate the national research situation and cooperation relationships in this research field through studies. Supplementary Figure 5A lists the countries with the most cited articles, with China topping the list, followed by the United States, South Korea, Singapore, and others. The horizontal axis represents the number of citations of the articles published by each country. Supplementary Table 5 clearly shows the contributions and H-INDEX influence of each country in this research field. Supplementary Figure 5B shows the cooperative connections among various countries, where nodes represent countries, the thickness of the lines indicates the degree of cooperation, and the colors represent the differences in the direction of cooperation. Supplementary Figure 5C, through a timeline, demonstrates the continuity of specific research topics over the past 10 years. Among them, China has been active in multiple aspects of research. Therefore, these pictures show the contribution and connection situations of the main research countries in this field. The most cited literature in this field The following is an analysis of the highly cited literature in this field. Fig. 2A shows the annual citation counts of the top 10 most cited articles. Supplementary Table 6 presents a more intuitive view of the annual citation counts of different articles over the past 10 years. Fig. 2B displays the citation relationship map of this field, where nodes represent articles, lines indicate the connections between articles, and node colors reflect the relevance of the research directions of the articles. Fig. 2C uses a Sankey diagram to show the flow and connections of highly cited articles, authors, and research topics in the citation relationship, facilitating the tracking of the connections among articles, authors, and topics. Analysis of the Most Cited Articles. A: Annual Variations in Cited Articles; B: Analysis of Research Connections Among Cited Articles; C: Three-Fields Plot Illustrating the Connections Among Literature, Authors, and Keywords. Analysis of key keywords in this field The keywords highly summarize the research directions and methods of each article. The frequency of keyword occurrence to some extent reflects the popularity of the research direction. Fig. 3A lists the 25 most frequently occurring keywords and presents their occurrence frequencies in the form of a bar chart. Among them, keywords such as "radiofrequency ablation" and "tumor microenvironment," which are closely related to our study, are also included, indicating that they are core hotspots in this field. Fig. 3B illustrates the interrelationships among tumors, immunotherapy, and the aforementioned keywords. Fig. 3C shows the keyword association and evolution trend through a timeline. Fig. 3D lists the start and end years of the BURST of high-frequency keywords from 2016 to 2025, allowing for a clear observation of the research popularity and duration of each keyword in different years. Overall, these results comprehensively reveal the composition, association, and evolution trend of keywords in this field. Keyword Analysis. A: Count of the Most Frequently Used Keywords; B:Keyword Network; C: Timeline View of Keyword Changes and Connections; D: BURST View Illustrating the Research Popularity of Keywords. Trend topic analysis in this field Continue to explore the popular research topics in this field. Fig. 4A shows the evolution of popular topics in different years, visually presenting the changes in the attention paid to topics such as "targeted drug delivery", "apoptosis", "immunogenic cell death", "ferroptosis", and "tumor microenvironment" over time. These topics also represent the hotspots of mechanism research in this field. Fig. 4B is a radar chart, showing the disciplines involved in the ablation and immune microenvironment we focus on (such as materials science, chemistry, and immunology). Fig. 4C is a four-quadrant graph, using correlation (centrality) and development (density) as dimensions to predict whether research topics are emerging or declining. For example, "tumor immune microenvironment" is closely related to other topics, while "immunotherapy" shows a high potential for development. Fig. 4D shows the connections and evolution of different themes in various time periods (such as 2016–2020, 2021–2023, 2024–2025) through nodes and connecting lines, revealing the continuity of research themes. This figure provides a comprehensive and in-depth analysis of the popular topics and their dynamic changes in this field. Trend Topic Analysis. A: Evolution of Trend Topics; B: Directions of Research Hotspots; C: Thematic Map Illustrating Prevalent Research Themes; D: Display of Research Hotspots in Different Time Periods. Correlation between this field and immunotherapy Reviewing the previous literature, the hot topic related to our research on "ablation" and "tumor immune microenvironment" is "immunotherapy". Therefore, we took the intersection of the included literature in the WOS database with "immunotherapy", obtaining a total of 537 articles for bibliometric analysis. Fig. 5A presents the frequency of popular keywords in the form of a word cloud, with "cancer treatment" and "immunotherapy" having relatively high proportions. Fig. 5B visually displays the connections among the research topic keywords, where the size of the nodes represents the word frequency and the number of lines indicates the strength of the association. Fig. 5C, based on the timeline, shows the evolution and correlation of different research topics, revealing the dynamic changes of research topics over time. Fig. 5D presents the changes in trend topics in different time periods. Fig. 5E identifies which topics are current research hotspots and which have future development potential through a quadrant chart. Fig. 5F lists the most highly cited and influential articles in this field. Figs. 5G and 5H: Through H-INDEX and quantity, they show the journals with the most publications in this field, reflecting their status in the minds of researchers. Therefore, for the difficult problem of tumor treatment, by changing the "tumor immune microenvironment" through "ablation", ultimately making patients suitable for immunotherapy, the treatment level of tumors has been improved. Research Status of Immunotherapy in This Field. A: Word Cloud of Immunotherapy-Related Terms; B: Connections Between Major Studies; C: Timeline Displaying Research Connections; D: Trend Topic Analysis of Research Hotspots; E: Thematic Map Illustrating Prevalent Themes; F: Display of the Most Cited Articles; G: Most Influential Literature in This Field; H: Analysis of the Most Relevant Journals in This Field. Discussion The intersection of ablation and the tumor immune microenvironment has emerged as a prominent research hotspot in recent years, with China leading in publication volume and maintaining close collaborations with the United States and other countries. Key findings have been predominantly published in high-impact journals such as ACS Applied Materials & Interfaces, Chemical Engineering Journal, ACS Nano, and Biomaterials. Authors including Liu Zhuang and Yang Piaoping have made substantial contributions, while the Chinese Academy of Sciences and Shanghai Jiao Tong University stand as leading institutions. Research primarily focuses on "radiofrequency ablation" and "tumor microenvironment," with deepening integration into immunotherapy, offering novel strategies for cancer treatment with broad prospects. Citation analysis of highly cited literature reveals breakthroughs spanning from basic mechanisms to clinical application in the ablation–immune microenvironment field. Zhou et al. demonstrated that ablation enhances ROS-mediated tumor killing [14]; Chen Q et al. developed smart Albumin-MnO₂ NPs that alleviate hypoxia, enhance ablation efficacy, and promote immune cell infiltration [15]; Yang et al. created an H-MnO₂ nanoplatform that generates O₂ to activate cGAS-STING, mature dendritic cells, and trigger systemic anti-tumor immunity [16]. A 2019 Chemical Reviews paper proposed ROS-based nanomedicine for precise tumor ablation and immune microenvironment remodeling [17]; Pushalkar et al. found that microbiota elimination restores immune recognition and enhances ablation efficacy in pancreatic cancer [18]; and a 2021 Chemical Society Reviews article reviewed photosensitizer design to overcome tumor microenvironment tolerance and boost anti-tumor immunity [19]. Collectively, these studies integrated physical ablation with immunomodulation, driving the paradigm from local control to systemic immune activation. Ablation affects the tumor immune microenvironment and the efficacy of immunotherapy, which has been confirmed by many studies. For instance, cryoablation and thermal ablation in lung cancer activate the cGAS-STING signaling pathway, increase the number of CXCL10+ macrophages and CXCL10 secretion, and enhance the efficacy of PD-1 monoclonal antibody [20]. Through a lung cancer mouse model and single-cell and T-cell receptor (TCR) sequencing data, it was found that cryoablation reprograms the immune microenvironment within the tumor, significantly increasing the CD8+ T cell subpopulation in circulation and pro-inflammatory cytokines, and synergistically enhancing the anti-tumor effect of PD-1 monoclonal antibody through the STING-dependent type I IFN signaling pathway [21]. In the above-mentioned articles, the alteration of the tumor microenvironment is an important intermediate factor, and its impact on the efficacy of immunotherapy has been widely reported. For example, through genetic engineering, Escherichiacolicontinuously synthesizes arginine and generates nitric oxide, and the intratumoral colonization of the arginine-nitric oxide circuit induces vascular normalization and dendritic cell recruitment, reduces tumor immunosuppression, amplifies functional CD8+ T cells, reverses T cell exhaustion, and promotes the formation of memory T cells, significantly enhancing the anti-tumor effect of αPD-L1 immunotherapy [22]. By integrating single-cell sequencing data of B cells from 649 patients with 19 major cancer types, tumor-associated atypical B cells (TAABs) have high clonal expansion levels and proliferation capabilities, and closely interact with activated CD4 T cells in tumors, which can predict the response to immunotherapy [23]. However, we cannot overlook the fact that research in this field has yielded different results. After cryoablation, there is a significant infiltration of neutrophils in the tumor microenvironment, which transform into immunosuppressive N2 type and simultaneously trigger the formation of NETs. This process hinders the cytotoxicity of CD8+ T cells against tumors through the CXCL2-CXCR2-Ca2+-PAD4 signaling axis, promoting immune escape [24]. Another study has shown that although radiofrequency ablation can induce certain immune responses, the changes in immune cells are dynamic and not continuously unidirectional as the operation time extends. This dynamic process does not have a synergistic effect with tumor recurrence [25]. Current research in the field of ablation and tumor immune microenvironment focuses on mechanism deepening and clinical translation breakthroughs. Key findings include: Ablation induces immunogenic cell death (ICD), releasing damage-associated molecular patterns (DAMPs, such as calreticulin and high-mobility group box B1) [26] and activating the cGAS-STING pathway, while reshaping the tumor metabolic microenvironment [27] (e.g., elevated butyrate levels), thereby enhancing CD8+ T cell infiltration. Combining ablation with immunotherapy requires precise timing within the "post-ablation immune window" (3–7 days) to maximize synergistic effects, whereas nanomaterial-assisted precision ablation techniques [28] (e.g. gold nanorod photothermal ablation) reduce normal tissue damage and strengthen immunogenic cell death. Single cell sequencing [29] demonstrates that ablation induces a phenotypic shift in the tumor microenvironment towards immune activation, evidenced by M1 macrophage polarization and decreased regulatory T cells (Tregs) [30]; yet resistance mechanisms include infiltration of myeloid-derived suppressor cells [31] or loss of major histocompatibility complex class I (MHC-I) expression [32], requiring combination with epigenetic modulators or CXCR2 inhibitors to overcome [33]. In clinical translation, PD-L1 expression, tumor mutational burden and butyrate-producing bacterial abundance are used as biomarkers responsible for the composition of personalized combination therapies, whereas liquid biopsy-derived monitoring of circulating tumor DNA dynamics serves as a prognostic tool to quantify early efficacy [34]. Taken together, these studies take the field beyond localized physical destruction towards systemic immune modulation with exciting new strategies to overcome tumor immunotherapy resistance. Currently, interventional therapy, leveraging its core advantages of minimal invasiveness, precision, rapid recovery, and high repeatability, has become an indispensable key modality within the comprehensive tumor treatment framework [35]. Its technical system primarily encompasses intravascular interventional and non-vascular interventional approaches, widely applied in clinical practice for solid tumors such as liver, lung, and renal cancers. Regarding intravascular intervention, transcatheter arterial chemoembolization (TACE) [36] combined with sorafenib achieved an objective response rate (ORR) of 46.7% and extended median overall survival to 13.8 months in advanced hepatocellular carcinoma [37]; hepatic arterial infusion chemotherapy (HAIC) continuously infuses fluorouracil and oxaliplatin via the hepatic artery, raising the conversion resection rate for colorectal cancer liver metastases to 23.8% [38]; drug-eluting microspheres (e.g., DC-Beads) continuously release doxorubicin or irinotecan while embolizing tumor vasculature, achieving high intratumoral drug concentration and significantly reducing hepatobiliary complications [39]. In terms of non-vascular intervention, various ablation techniques each possess distinct characteristics: radiofrequency ablation (RFA) [40], and microwave ablation (MWA), as representatives of thermal ablation, directly inactivate tumor cells through high temperatures, are widely applied to liver, lung, and renal cancers with confirmed efficacy and minimal trauma; cryoablation destroys tumor cells via rapid freeze-thaw cycles, with the unique advantage of effectively activating the cGAS-STING signaling pathway, promoting CXCL10+ macrophage infiltration, and significantly enhancing synergistic effects with immunotherapy; radioactive seed implantation [41] achieves local tumor control through continuous low-dose radiation with additional immunomodulatory potential; ⁹⁰Y-FAPI-46 radioligand therapy [42] targets fibroblast activation protein (FAP) in the tumor microenvironment, providing a novel precision therapeutic option for advanced solid tumors; irreversible electroporation (IRE) disrupts tumor cell membranes via high-voltage electric pulses [43], avoiding the "heat sink effect" of thermal ablation and effectively preserving adjacent bile ducts and vascular structures. Collectively, these technologies drive a paradigm shift in tumor treatment from local control toward systemic immune regulation across multiple dimensions. Interventional therapy has far outgrown its traditional identity as mere local physical destruction. With inherent advantages of minimal invasiveness, precision, and repeatability, it has seamlessly integrated with systemic and mainstream therapies, establishing a synergistic treatment paradigm. The clinical evidence speaks clearly: TACE plus sorafenib significantly prolongs survival in hepatocellular carcinoma; HAIC raises conversion resection rates for colorectal liver metastases; drug-eluting microspheres deliver high intratumoral drug concentrations with fewer complications; and emerging technologies like IRE have surpassed the constraints of thermal ablation. Most strikingly, the ablation–immunotherapy combination has moved from bench to bedside—neoadjuvant conversion renders inoperable tumors resectable, while "ablation plus immunotherapy" enables long-term survival in tumor-bearing patients. Biomarkers including PD-L1 expression, TMB, and butyrate-producing bacteria now guide personalized regimens, with ctDNA monitoring enabling early response assessment. These findings confirm that ablation is no longer an adjunct to conventional therapy but a core modality that complements—and may even lead—surgery, targeted therapy, and immunotherapy. The evidence is now strong enough to reshape clinical decision-making. Clinicians must rethink the role of ablative therapy: it is no longer simply a "backup when surgery fails" or a "palliative add-on," but a central strategy spanning the full continuum of tumor care, driving a shift from local control to systemic immune regulation. The priority now is identifying the right patients: elderly patients unfit for surgery, those with oligometastases needing intensified local control, patients requiring rapid downstaging for conversion therapy, and tumor-bearing patients who stand to gain long-term survival or even cure through combined immunotherapy. Only by building a rigorous patient selection framework—matching the right patient to the right intervention at the right time—can we fully realize ablation's potential: maximal tumor control with minimal invasiveness. Expanding early access for suitable patients is not just a logical extension of current practice—it is a clinical imperative for precision oncology and improved patient outcomes. There are three major trends in future development, first is the deep integration of minimally invasive and intelligence. For example, China's self-developed interventional robots have reached an operating accuracy of 0.1 mm. If combined with low-dose digital subtraction angiography (DSA, 60% cut on radiation dose) and AI-enabled three-dimensional walk path planning, they can automatically bypass the more branched vasculature and nerve bundles [44]. Second, building up individualized treatment systems with keeping track of through genomics and liquid biopsies [45]. For instance, ctDNA profiling may reveal the presence of EGFR mutations or PD-L1 expression status and facilitate precision treatment with TACE plus osimertinib or pembrolizumab [46]. Third, innovations in combinations of multipmodalities therapies. Tumor-associated antigens(TAAs) released following ablation or embolization have the potential to activate dendritic cells (DCs) [47]. This strategy enhances CD8+T cell infiltration threefold in the presence of anti-PD-1 antibodies. On the other hand, nanomaterials-mediated photothermal ablation (e.g. gold nanorods) triggers immunogenic cell death(ICD) by specific temperature control (42–45 °C), which also contributes to stimulating the anti-tumor immunity [48]. Moreover, gene editing technologies (e.g., CRISPR-Cas9) [49] and microbiome modulation (e.g., butyrate-producing bacteria transplantation) [50] have revealed new strategies to bypass drug resistance as well as the remodeling of the tumor immune microenvironment. Under the popularization and price reduction of domestic equipment, the implementation of a new paradigm for tumor treatment of "localized precise intervention combined with systemic immune activation [51]" is being accelerated. This study has certain limitations. The analyzed data were sourced exclusively from the WoSCC database, and to ensure complete annual data, articles published in 2026 were excluded, which may introduce source bias. However, this study encompassed 5328 publications; incorporating additional databases would substantially increase the volume, making analysis unwieldy, while data formats from other databases differ from WoSCC with partial information missing. Therefore, only WoSCC was included. Another limitation is that different ablation modalities exert distinct effects on the tumor immune microenvironment; constrained by the scope of this study, ablation was discussed as a unified whole without elaborating on modality-specific impacts to avoid excessive length or content redundancy. Conclusion Research at the intersection of ablation and the tumor immune microenvironment is surging, with ablation having evolved from mere local destruction to a core strategy that reshapes the immune microenvironment in tumor treatment. Its combination with immunotherapy demonstrates tremendous translational potential and clear clinical value, warranting widespread promotion under guideline recommendations while urgently calling for more high-quality studies for further validation. Funding This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Data statement The data presented in the study are included in the article and supplementary materials. More original data are from www.webofscience.com. CRediT authorship contribution statement Sibo Meng: Writing – review & editing, Writing – original draft, Visualization, Software, Resources, Methodology, Formal analysis. Jiaxin Li: Writing – review & editing, Writing – original draft, Software, Methodology, Formal analysis, Data curation. Fangli Cao: Writing – review & editing, Supervision, Conceptualization. Hongxin Niu: Writing – review & editing, Supervision, Investigation, Conceptualization. Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. Footnotes Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.tranon.2026.102855. Contributor Information Fangli Cao, Email: caofangliqilu@163.com. Hongxin Niu, Email: sdblache@126.com. Supplementary materials References Associated Data Supplementary Materials